IPO - SCWorx Corp.

Form Type: CORRESP

Filing Date: 2025-04-23

Corporate Action: Ipo

Type: New

Accession Number: 000121390025034598

Filing Summary: SCWorx Corp. submitted a request to the Securities and Exchange Commission to accelerate the effectiveness of its Registration Statement on Form S-1, which is designated under File No. 333-284893. The company seeks for it to become effective on April 25, 2025, at 5:00 p.m. Eastern Time. The document acknowledges the company's obligations under the Securities Act, emphasizes that approval from the Commission does not waive its responsibilities for the Statement's accuracy, and clarifies that the company cannot use the effectiveness as a defense in any legal proceedings. The communication is signed by CEO Timothy Hannibal, and there is a request for confirmation of the effectiveness through counsel.

Form Type: S-1/A

Filing Date: 2025-04-16

Corporate Action: Ipo

Type: Update

Accession Number: 000121390025032610

Filing Summary: SCWorx Corp. filed an amendment to its Form S-1 registration statement for an initial public offering on April 16, 2025. The company, based in Delaware, is offering up to 40,000,000 shares of its common stock for resale by selling stockholders. This offering is tied to the issuance of senior secured convertible notes and related stock purchase agreements made in prior years. The prospectus details the company's history, governance, and its market strategy focusing on data services within the healthcare sector. It also outlines the risks associated with investing in SCWorx, referencing the uncertain regulatory landscape and operational risks. Moreover, the structure of the offering and the current trading status of its common stock under the Nasdaq symbol 'WORX' are emphasized, as well as the financial performance metrics that investors should consider before purchasing shares.

Form Type: S-1

Filing Date: 2025-02-13

Corporate Action: Ipo

Type: New

Accession Number: 000121390025013187

Filing Summary: On February 13, 2025, SCWorx Corp. filed a Form S-1 Registration Statement with the SEC for the proposed sale of up to 40,000,000 shares of its common stock by Selling Stockholders. The common stock will be offered in connection with previously issued senior secured convertible notes and warrants from July 2024 and January 2025, and a settlement agreement also tied to shares. The prospectus outlines their business model focusing on data integration and interoperability for healthcare providers, emphasizing operational benefits like cost reduction and improved billing efficiency. SCWorx provides advanced software solutions, primarily via a SaaS model, and operates with the aim of enhancing data management in healthcare settings. The company's common stock is listed on Nasdaq under the symbol 'WORX,' and it’s noted that investing in the stock entails significant risks. The company clarifies that it will not receive any proceeds from the sale of shares by Selling Stockholders, but may realize funds from warrant exercises, which are intended for working capital purposes.